August 2015
NCI Standard Funding Opportunity Announcements |
|||||||||||||||||||
| Current and Recent Program Announcements | Current and Recent Requests for Applications | |||||||||||||||||||
|
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates |
|||||||||||||||||||
 |
Army Research Office Broad Agency Announcement (BAA)
The purpose of this BAA is to solicit research proposals in the
engineering, physical, life, and information sciences for
submission to the Army Research Office (ARO) for consideration
for possible funding.
| ||||||||||||||||||
| Due Dates: | Open until March 31, 2017 Proposers are to submit white papers prior to submission of a complete proposal. Based on assessment of white papers, feedback will be provided to encourage or discourage submission of full proposals. |
| Amount & Project Period: | No specific dollars have been reserved 3 years |
| Eligibility: | All Ranks |
| Contact: | Please contact your SRA |
| Links: |
ARO CORE
BAA-W911NF-12-R-0012-Mod 03 Army Research Laboratory BAAs |
| August 21 | Established Investigators | Non-federal | Gastric Cancer |
AGA Research Foundation
Robert & Sally Funderburg Research Award in Gastric Cancer
To support the research of an established investigator working
on novel approaches to gastric cancer.
| Due Dates: | August 19 (OSR) Ι August 21 (Sponsor) |
| Amount & Project Period: | $50,000/year - 2 years |
| Eligibility: | Must be established, independent investigator
in gastric biology AGA membership required at time of submission |
| Contact: | Linda Nolan (x6071) |
| FOA Link: | Guidelines |
NEW
| September 1 | See Below | Non-federal | See Below |
PhRMA Foundation 2016 Awards
Postdoctoral Awards
| Due Dates: | August 30 (OSR) Ι September 01 (Sponsor) |
| Eligibility: | Eligible applicants must 1) hold a Ph.D. degree or appropriate terminal research doctorate in a field of study logically or functionally related to the proposed postdoctoral activities or 2) expect to receive the Ph.D. before activating the award |
| Contact: | Linda Nolan (x6071) |
Informatics - To support the post-doctoral career development of individuals preparing to engage in research that will bridge the gap between experimental and computational approaches in genomic and biomedical studies
| Amount & Project Period: | $40,000/year - 2 years |
Adherence Improvement<\span class="auto-style143"> To provide stipend support for individuals engaged in a research training program that will extend their credentials in adherence improvement. To support the postdoctoral career development of individuals prepared to engage in research that will strengthen representation of adherence improvement in schools of pharmacy, medicine, nursing, and public health.
| Amount & Project Period: | $50,000 - 1 year |
Pharmaceutics - Pharmaceutics is the science that deals with drug delivery systems, in particular, the design and evaluation of contemporary pharmaceutical dosage forms and systems to ensure their safety, efficacy, and reliability.
| Amount & Project Period: | $40,000 - 1 year |
Pharmacology / Toxicology - Supports career development activities of scientists embarking on research that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, in experimental animal or clinical studies or both.
| Amount & Project Period: | $40,000 - 1 YEAR (Stipend ONLY) |
Research Starter Grants
| Due Dates: | August 30 (OSR) Ι September 01 (Sponsor) |
Adherence Improvement - Supports research that will advance knowledge of innovative and effective approaches to improve medication adherence. Relevant research goals may include development or evaluation of policies, interventions, or tools that have potential to improve medication adherence.
| Amount & Project Period: | $50,000 - 1 year |
| Eligibility: | Individuals holding academic rank of instructor, assistant professor, or investigator at the doctoral level by January 2015 are eligible |
Informatics - to promote development and use of informatics in an integrative approach toward understanding normal processes of human biology and disease processes.
| Amount & Project Period: | $100,000 - 1 year |
| Eligibility: | Those holding academic rank of assistant professor (or research assistant professor) within a tenure track (or research track) appointment, i.e., not instructor, are eligible. |
Pharmaceutics - strongly emphasizes quantitative understanding and use of the principles underlying drug delivery and drug transport, whether a drug is a small organic molecule, a higher molecular weight peptide, a protein derived through biotechnology, or an oligonucleotide-like molecule for gene therapy.
| Amount & Project Period: | $100,000 - 1 year |
| Eligibility: | Those holding academic rank of Assistant Professor (or Research Assistant Professor) w/in a tenure track (or Research track) appointment, or Instructor, if eligible to apply for independent research funding by their institution, are eligible. |
Pharmacology / Toxicology -support career development activities of scientists embarking on research that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, in experimental animal or clinical studies or both.
| Amount & Project Period: | $100,000 - 1 year |
| Eligibility: | Those holding the academic rank of Assistant Professor (or Research Assistant Professor) within a tenure track (or Research track) appointment, or Instructor, if eligible to apply for independent research funding by their institution, are eligible. |
| September 1 | Established Investigators | Non-federal | Childhood All |
USC Parker Institute for Childhood Cancer Research & the William Lawrence & Blanche Hughes Foundation
Pediatric Grant
Applications
The goal is to develop novel therapies for childhood acute
lymphocytic leukemia. Priority will be given to those grants that have a
translational bent on getting new therapies to children with
leukemias.
| Due Dates: | August 25 (OSR) Ι September 1 (Sponsor) |
| Amount & Project Period: | $150,000/year (Direct Costs) - up to 3 years |
| Eligibility: | Established investigators |
| Contact: | Linda Nolan (x6071) |
| Link: | http://aspho.org/career-development/funding-opportunities-and-news |
NEW
| September 01 (LOI) | See Specific Announcement | Non-federal | Career Development |
Leukemia & Lymphoma Society
Career Development Program
Opportunity to take part in basic, clinical or translational
research to help understand and treat hematologic malignancies
and relevant premalignant conditions Career development awards are available for various stages of a research career
| Due Dates: | Sept 01 (Letter of Intent) Full Applications: Sept. 28 (OSR) Oct 01 (Sponsor) |
| Amount & Project Period: | Scholar - ($110,000/yr - 5 years) Scholar in Clinical Research ($110,000/yr - 5 years) Special Fellow ($65,000/yr - 2-3 years) Fellow - $55,000/yr - 3 years |
| Eligibility: | Letter of Intent is used to determine eligibility |
| Contact: | Linda Nolan (x6071) |
| Link: |
Career
Development Program o Scholar - ($110,000/yr - 5 years) o Scholar in Clinical Research ($110,000/year - 5 years) o Special Fellow ($65,000/yr - 2-3 years) o Fellow - $55,000/yr - 3 years |
| September 2 | All Faculty | Non-Federal | Lymphoma |
Lymphoma Research Foundation
Follicular Lymphoma Pathways
Seeks proposals for high-quality research
studies in follicular lymphoma (FL).
Applications must include the
study of primary FL patient samples to assure
relevance to the human disease. In addition,
applicants are required to explicitly delineate
how the proposed research will incorporate
collaborative interactions between/among
investigators in different disciplines (e.g.
pathology and medical oncology, basic science
research and clinical investigators) and/or
different institutions.| Due Dates: | August 25 (OSR) Ι September 2 (Sponsor) |
| Amount & Project Period: | $150,000/year (direct costs) for up to 3 years |
| Eligibility: | All ranks |
| Contact: | Linda Nolan (x6071) |
| Links: |
Available Grant Opportunities Guidelines and General Instructions for Application |
| September 2 | All Faculty | Non-Federal | Lymphoma |
Lymphoma
Research
Foundation
Clinical
Investigator
Career
Development
Award
All projects
must be focused
on
hypothesis-driven
clinical
research in
lymphoma.| Due Date | August 25 (OSR) Ι September 2 (Sponsor) |
| Amount & Project Period: | $225,000 total over 3 years |
| Eligibility: | All ranks |
| Contact: | Linda Nolan (x6071) |
| Links: |
Available Grant Opportunities Guidelines and General Instructions for Application |
| September 2 | Postdoctoral Fellows | Non-Federal | Lymphoma |
Lymphoma Research Foundation
Postdoctoral Fellowships
The LRF Postdoctoral Fellowship Grant is designed to support investigators at the level of
advanced fellow, postdoctoral researcher, or junior faculty member in laboratory or clinic based
research with results and conclusions that must be clearly relevant to the treatment, diagnosis or
prevention of Hodgkin and/or non-Hodgkin lymphoma.| Due Dates: |
August 25 (OSR) September 2 (Sponsor) |
| Amount & Project Period: | $105,000 total over 2 years. |
| Eligibility: | Applicants must have completed two years of their fellowship or postdoctoral work, or not more than two years as a junior faculty instructor or assistant professor at the start of the award period and hold an MD, PhD, or equivalent degree. |
| Contact: | Linda Nolan (x6071) |
| Links: |
Available Grant Opportunities Guidelines and General Instructions for Application |
| R41/R42 | NIH |
New FOA
| September 05 | SBCs | Federal | Tech Transfer |
PHS 2015-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications stimulate technological innovation in the private sector; strengthen the role of small business in meeting Federal research or research and development (R/R&D) needs
| Due Dates: | September 5th (Standard dates) |
| Amount & Project Period: | Phase 1: $150,000 (TOTAL) - 1 year Phase 2: $1,000,000 - 2 years |
| Eligibility: | Moffitt must be a subawardee. Primary employment of PD/PI must be w/small business concern at time of award and during conduct of project. For projects with multiple PDs/PIs, at least 1 must meet the primary employment requirement |
| Contact: | Christi Craig - (X1458) |
| FOA Link: | PA-15-269 |
| R43/R44 | NIH |
New FOA
| September 05 | SBCs | Federal | Tech Transfer |
PHS 2015-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications
Intended to stimulate a partnership of ideas and technologies between innovative small business concerns (SBCs) and non-profit research institutions through Federally-funded research or research and development (R/R&D).| Due Dates: | September 5th (Standard dates) |
| Amount & Project Period: | Phase 1: $150,000 (TOTAL) - 1 year Phase 2: $1,000,000 - 2 years |
| Eligibility: | Moffitt is a subawardee. Small Business Concerns |
| Contact: | Christi Craig - (X1458) |
| FOA Link: | PA-15-270 |
| U01 | NCI |
NEW
| September 06 (LOI) | All Faculty | Federal | BD2K |
Big Data to Knowledge (BD2K) Development of Software Tools and Methods for Biomedical Big Data in Targeted Areas of High Need
To solicit development of software tools and methods in the three topic areas of data privacy, data repurposing, and applying metadata, all as part of the overall BD2K initiative. While this FOA is intended to foster new development, submissions consisting of significant adaptations of existing methods and software are also invited| Due Dates: | September 06 (Letter of Intent) Applications: October 04 (OSR) Ι October 06 (Sponsor) |
| Amount & Project Period: | $300,000/yr (Direct Costs) - 3 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (X6071) |
| RFA Link: | RFA-CA-15-017 |
| R01/R21/R03 | NIH |
NCI is a participating institute
New FOA Numbers
| September 07 | All Ranks | Federal | HIV and Aging |
Multidisciplinary Studies of HIV/AIDS and Aging
to study HIV infection, HIV-associated conditions, HIV treatment, and/or biobehavioral or social factors associated with HIV/AIDS in the context of aging and/or in older adults. Research approaches of interest include clinical translational, observational, and intervention studies in domestic and international settings.| Due Dates: |
Standard AIDS dates: Sept 05 (OSR) Ι Sept 07 (Sponsor)
All types allowed for this RFA are due on Sept. 07 |
| Amount & Project Period: | R01: Budgets not limited - 5 years R21: $275,000 (Direct Costs) - 2 years R03: $50,000/yr (Direct Costs) - 2 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| FOA Links: |
PAR-15-280 - R01 PAR-15-282 - R21 PAR-15-281 - R03 |
| R01 | NIH |
NEW
| September 07 | All Ranks | Federal | Big Data and HIV |
Harnessing Big Data to Halt HIV
To promote research that transforms understanding of HIV transmission, the HIV care continuum, and HIV comorbidities using Big Data Science (BDS).| Due Dates: | Standard AIDS dates Ι Sept 05 (OSR) Ι Sept 07 (Sponsor) |
| Amount & Project Period: | Budgets are not limited - 5 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| FOA Link: | PA-15-273 |
| R01 | NCI |
NEW
| September 08 (LOI) | All Faculty | Federal | Smoking and Lung Cancer Screening |
Smoking Cessation within the Context of Lung Cancer Screening
To improve the effectiveness and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening.| Due Dates: | September 08 (Letter of Intent) October 06 (OSR) Ι October 08 (Sponsor) |
| Amount & Project Period: | Limited to $500,000 Direct Costs in any one year - 5 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (x6071) |
| RFA Link: | RFA-CA-15-011 |
| R01 | NIH |
NEW
| September 09 (LOI) | All Ranks | Federal | Career Support |
NIH Transformative Research Awards
Supports individual scientists or groups of scientists proposing groundbreaking, exceptionally innovative, original and/or unconventional research with the potential to create new scientific paradigms, establish entirely new and improved clinical approaches, or develop transformative technologies.| Due Dates: | Sept 09 (Letter of Intent) Ι Oct 07 (OSR) Ι Oct 09 (Sponsor) |
| Amount & Project Period: | Budgets not limited - 5 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (X6071) |
| RFA Link: | RFA-RM-15-005 |
NEW
| September 09 (LOI) | Jr Faculty | Non-federal | Genetics/Cell Biology/Immunology |
Concern Foundation
NOW Award
Proposals must be hypothesis-driven and centered on cancer genetics, cancer cell biology, or cancer immunology. Concern will not fund clinical trials, cancer epidemiology, or behavioral studies.
| Due Dates: | September 09 (Pre-proposal) Invited Applications: Dec 07 (OSR) Ι Dec 09 (Sponsor) |
| Amount & Project Period: | $60,000/yr - 2 years |
| Eligibility: | Jr faculty Priority given to proposals from independent investigators who have yet to obtain significant funding |
| Contact: | Linda Nolan (X6071) |
| Links: |
2015 Call for Applications and LOI Guidelines Concern Foundation (Homepage) |
NEW
| Sept 18 (Pre-proposal) | All Faculty | Federal | Breast |
Congressionally Directed Medical Research Programs
Breast Cancer Research Program
Breakthrough Award Level 3
W81XWH-15-BCRP-BREAKTHROUGH2_FL3
To support promising research that has high potential to lead to or make breakthroughs in breast cancer Funding Level 3: Advanced translational studies that have potential for near-term clinical investigation. Small-scale clinical trials may apply
| Due Dates: | September 18 (Letter of Intent) Invited Applications: December 19 (OSR) Ι December 21 (Sponsor) |
| Amount & Project Period: | $2.5M (Direct Costs) - 5 years |
| Eligibility: | All Faculty Investigators invited to apply to the Breakthrough 3-4 opportunity may not submit the same project to this initiative. Each individual may submit only one pre-application as a PI or Initiating PI. |
| Contact: | Linda Nolan (x6071) |
| RFA Link: | W81XWH-15-BCRP-BREAKTHROUGH2_FL3 |
| September 18 (Pre-app) | Postdocs | Non-federal | Difficult-to-treat cancers |
The Hope Funds for Cancer Research
Postdoctoral Fellowship
The Hope Funds for Cancer Research is
offering fellowships to postdoctoral scientists
who propose to work on highly innovative
research projects that challenge the traditional
paradigms of understanding the causes,
mechanisms, progression, disease markers or risk
factors of the most difficult-to-treat cancers,
including pancreatic, lung, liver, sarcomas,
esophageal, brain, gastric, bone and ovarian
cancers; and rare leukemias, lymphomas and MDS.| Due Dates: |
September 18 - Pre-application Invited Applications: January 26 (OSR) Ι January 28 |
| Amount & Project Period: | $48,000 stipend - year 1 $50,000 stipend - year 2 $52,000 stipend - year 3 |
| Eligibility: | Must have completed a doctorate
degree. Must have been in Sponsor's lab <2 years as of September 18, 2015 |
| Contact: | Linda Nolan (x6071) |
| Links: | Hope Funds Postdoctoral Fellowship RFA |
| September 24 | Jr Clinical Faculty | Non-federal | Career Development |
2016 Conquer Cancer Foundation
Career Development
Award
The Career Development Award (CDA) provides funding to
early career clinical investigators to establish
an independent clinical cancer research program.
The cancer research must have a patient-oriented
focus, including a clinical research study
and/or translational research involving human
subjects. | Due Dates: | September 21 (OSR) Ι September 24 (Sponsor) |
| Amount & Project Period: | $200,000 total over 3 years |
| Eligibility: | Physician w/in first 3 years of faculty
appointment. Candidates may not have existing Career Development funding |
| Contact: | Linda Nolan (x6071) |
| Links: | CCF CDA RFP |
| September 24 | Clinical Fellows | Non-federal | Clinical Oncology |
2016 Conquer
Cancer
Foundation
ASCO Young
Investigator
Award
The purpose of this award is to fund physicians during the transition from a fellowship program to a faculty appointment. The
Conquer Cancer Foundation welcomes application submissions in all oncology subspecialties.| Due Dates: | September 21 (OSR) Ι September 24 (Sponsor) |
| Amount & Project Period: | $50,000 total for 1 year |
| Eligibility: | Mentored physicians within last 2 years of final subspecialty training working in an oncology lab or clinical research setting. |
| Contact: | Linda Nolan (x6071) |
| Links: | CF YIA RFP |
NEW
| October 01 | Postdocs | Non-federal | Career Development |
Cancer
Research
Institute
Postdoctoral
Fellowship
Cancer immunology fellowship seeks hypothesis driven, mechanistic
studies in both
immunology and
tumor
immunology.
Applicant and
sponsor must
clearly state
potential of
proposed studies
to directly
impact
understanding of
the immune
system's role in
cancer risk,
tumor
initiation,
progression,
metastasis, host
response to
tumors and/or
the treatment of
cancer| Due Dates: | September 29 (OSR) Ι October 01 (Sponsor) |
| Amount & Project Period: | Stipend: $50,000, 1st year; $53,000 2nd year, $57,000 3rd year Allowance: $1,500/year for use at sponsor's discretion to help pay for fellow's research supplies, travel to scientific meetings, and/or health insurance. |
| Eligibility: | Must be working in areas directly related to
cancer immunology Must have doctoral degree by award activation
One fellow per sponsor may apply per application round No citizenship restrictions |
| Contact: | Linda Nolan (x6071) |
| Link: | Postdoctoral Fellowship Application Guidelines |
NEW
| October 01 | Postdocs | Non-federal | Career Development |
Life
Sciences
Research
Foundation
Postdoctoral
Fellowship
Supports training in all areas of the life sciences. System opens on
September 09 for
new applications
| Due Dates: | October 01 |
| Amount & Project Period: | $60,000/yr - 3 years |
| Eligibility: | Individuals who have held a PhD or MD degree for less than 5 years at the time of application are eligible |
| Contact: | Linda Nolan (6071) |
| Link: | Application Instructions |
| R01/R21 R03/R15 |
NIH |
NCI is a participating institute
NEW
| October 05 | All Ranks | Federal | SGM Populations |
The Health of Sexual and Gender Minority (SGM) Populations
Supports research to increase scientific understanding of the health status of diverse population groups and thereby improve effectiveness of health interventions and services for individuals within those groups. Priority is placed on understudied populations with distinctive health risk profiles| Due Dates: | Standard dates |
| Amount & Project Period: | R01: Budgets not limited -
5 years R21: $275,000 (Direct Costs) - 2 years R03: $100,000 (Direct Costs) - 2 years R15: $300,000 (Direct Costs) - 3 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| FOA Links: |
PA-15-261 - R01 PA-15-263 - R21 PA-15-262 - R03 PA-15-260 - R15 Academic Research Enhancement Award |
| R01/R21 | NIH |
New FOA Numbers
| October 05 | All Ranks | Federal | Physical Activity & Weight Control |
Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival
Encourages transdisciplinary and translational research that will identify the specific biological or biobehavioral pathways through which physical activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer prognosis and survival.| Due Dates: | Standard dates apply |
| Amount & Project Period: | R01: Budget not limited - 5 years R21: $275,000 (Direct Costs) - 2 years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (X6071) |
| FOA Links: | R01:
PA-15-311 R21: PA-15-310 |
| Admin Supplement | NCI |
NEW
| October 07 | See Below | Federal | Supplemental Funding |
Assay Validation For High Quality Markers For NCI-Supported Clinical Trials
To improve the development and validation of molecular diagnostics for the treatment, control, or prevention of cancer| Due Dates: | October 05 (OSR) October 07 (Sponsor) |
| Amount & Project Period: | Limited to $150,000 in direct costs in any
single year May not exceed 3 years |
| Eligibility: | Must hold active grant or cooperative agreement, and research proposed for supplement must be accomplished within the competitive segment of the active award. |
| Contact: | Linda Nolan (X6071) |
| FOA Link: | PA-15-264 |
| Admin Supplement | NIH |
NCI is a participating institute
NEW
| October 15 | See Below | Federal | Supplemental Funding |
Administrative Supplements for Research on Dietary Supplements
To support research in which the supplemental funding would investigate the role of dietary supplements and/or their ingredients in health maintenance and disease prevention.| Due Dates: | October 13 (OSR) Ι October 15 (Sponsor) |
| Amount & Project Period: | $100,000 (Total Costs) - Limited to 1 year |
| Eligibility: | Active awards with at least 18 months remaining at time of submission will be considered. Awards in no-cost extension periods are not eligible. |
| Contact: | Linda Nolan (x6071) |
| FOA Link: | PA-15-258 |
| U24 | NCI |
NEW
| October 17 (LOI) | All Clinical Faculty | Federal | Imaging & Precision Medicine |
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine
Scientific Goals:(a) Perform appropriate optimization of pre-clinical quantitative imaging methods,
(b) Implement optimized methods in co-clinical trial, and finally
(c) Populate a web-accessible research resource with all data, methods, workflow documentation, and results collected from the co-clinical investigations.
| Due Dates: | October 17 (Letter of Intent) November 15 (OSR) Ι November 17 (Sponsor) |
| Amount & Project Period: | $500,000/yr (Direct Costs) - 5 years |
| Eligibility: | All Clinical Faculty |
| Contact: | Linda Nolan (X6071) |
| FOA Link: | PAR-15-266 |
| Admin Supplement | NCI |
NEW
| October 18 | See Below | Federal | Genomics |
Supplements to Support Evaluation of the NCI Cancer Genomics Cloud Pilots
To support projects that will incorporate the use of one or more of the NCI Cancer Genomics Cloud Pilots into ongoing research activities.| Due Dates: | October 16 (OSR) Ι October 18 (Sponsor) |
| Amount & Project Period: | $40,000 (Direct Costs) Must be w/in currently approved project period of existing parent award and work must be completed no later than September 30, 2016. |
| Eligibility: | Announcement is for supplements to existing
projects (R01, R21, U01, U24). Parent award must be active and research proposed in supplement must be accomplished w/in competitive segment. . |
| Contact: | Linda Nolan (x6071) |
| FOA Link: | PA-15-305 |
| U01/R01/R21 | NCI |
NEW
| October 23 (LOI) | All Ranks | Federal | Detection/Prevention/Risks |
Translational Research on Adducts in Cancer Risk Identification and Prevention
Encourages clinically-relevant translational/epidemiological research projects focused on the use of adducts to cellular macromolecules, as indicators of exposures to cancer risk factors in human populations and subgroups. Priority is on projects that will focus on adductomic approaches, i.e., address some aspects of the totality of adducts. Main emphasis is on advancing the area of cancer detection, cancer prevention, and assessing cancer risks in human populations and subgroups.| Due Dates: | October 23 (Letter of Intent) Applications: November 21 (OSR) Ι November 23 (Sponsor) |
| Amount & Project Period: | U01 & R01: Budgets not limited - years |
| Eligibility: | All Ranks |
| Contact: | Linda Nolan (x6071) |
| FOA Links: | U01:
PAR-15-307 R01: PAR-15-308 R21: PAR-15-309 |
| U01 | NCI |
NEW
| October 25 (LOI) | All Faculty | Federal | Pancreatic |
The Pancreatic Cancer Detection Consortium
To establish the Pancreatic Cancer Detection Consortium (PCDC) to conduct research to improve detection of early stage pancreatic ductal adenocarcinoma (PDAC) and characterization of its precursor lesions. Intended to support research for development and testing of new molecular and imaging biomarkers for identifying patients at high risk for PDAC who could be candidates for early intervention.| Due Dates: | October 25 (LOI) November 23 (OSR) Ι November 25 (Sponsor) |
| Amount & Project Period: | Budgets are not limited - 5 years |
| Eligibility: | All Faculty |
| Contact: | Linda Nolan (x6071) |
| FOA Link: | PAR-15-289 |
NEW
| October 28 | All Ranks | Federal | Physics/Cancer Biology |
National
Science
Foundation (NSF)
Directorate for
Mathematical &
Physical
Sciences
Division of
Physics
Investigator-Initiated
Research
Projects (PHY)
Physics of
Living Systems
Focus should be
on understanding
basic physical
principles that
underlie
biological
function.
From
Dear Colleague
Letter Below:
inter-
and
multi-disciplinary
research
at the
intersection of
physical and
life sciences
with a focus on
advancing the
fundamental
understanding of
cancer biology
to underpin
translational
research that
promotes the
prevention,
detection, and
treatment of
cancer
diseases...
| Due Dates: | October 26 (OSR) Ι October 28 (Sponsor) |
| Amount & Project Period: | Budget not limited - 3 to 5 years |
| Eligibility: | All Ranks |
| Contact: | At NSF:
Krastan B. Blagoev, Physics of Living Systems, Tel: (703) 292-4666,
email: kblagoev@nsf.gov Linda Nolan (x6071) |
| Links: |
NSF 15-579 Program Guidelines Dear Colleague Letter: Submission of Proposals to NSF Programs that Address the Interdisciplinary Topic of Theoretical Physics Approaches to Cancer Biology |
NEW
| November 01 (LOI) | All Faculty | Non-federal | Immunotherapies |
Cancer
Research
Institute
Clinic and
Laboratory
Integration
Program
Provides funding
to explore
clinically
relevant
questions aimed
at improving the
effectiveness of
cancer
immunotherapies.
Supports basic,
pre-clinical,
and
translational
research, which
will provide
information that
can be directly
applied to
optimizing
cancer
immunotherapy in
the clinic.
| Due Dates: | November 01 (Letter of Intent) Invited Applications: January 30 (OSR) Ι February 01 (Sponsor) |
| Amount & Project Period: | $100,000/year - 2 years |
| Eligibility: | Must hold faculty appointment as a tenure-track
assistant professor or higher at time of award activation. CRI has no citizenship restrictions, |
| Contact: | Linda Nolan (x6071) |
| Link: | CLIP Application Guidelines |
| U24 | NCI |
| November 17 | All Faculty | Federal | Co-Clinical Trials |
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine
The purpose of this FOA is to develop research that will encourage a consensus on how Quantitative Imaging (QI) methods are optimized to improve correlation of results for co-clinical trials; defined as investigations in patients and in parallel (or sequentially) in mouse or human-in-mouse models of cancer that mirror the genetics and biology of the patients' malignancies or pre-cancerous lesions.The scientific goals are to: (a) perform the appropriate optimization of the pre-clinical quantitative imaging methods, (b) implement the optimized methods in the co-clinical trial, and finally (c) populate a web-accessible research resource with all the data, methods, workflow documentation, and results collected from the co-clinical investigations.
Applicants are encouraged to organize multi-disciplinary teams with experience in mouse models research, human investigations, imaging platforms, QI methods, decision support software and informatics to populate the research resource.
| Due Dates: |
November 10 (OSR) November 17 (Sponsor) |
| Amount & Project Period: | $500,000/year for 5 years |
| Eligibility: | All Faculty |
| Contact: | Contact Dr. Robert Gillies |
| FOA Link: | PAR-15-266 |
| X02 | NIH |
NEW
December 16 |
All Faculty | Federal | Collaborative/Translational Research |
Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center
To accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research w/in labs and clinics of the NIH) and extramural investigators. NCI encourages bench-to-bedside research to: increase understanding of molecular and physiological basis of health and disease; stimulate clinical discoveries about mechanisms underlying disease to develop improved prevention, diagnosis, and treatment; enable translation of basic discoveries into clinical practice; foster training and mentoring of emerging scientists and physicians; and communicate research advances to public.| Due Dates: | December 14 (OSR) Ι December 16 (Sponsor) |
| Amount & Project Period: | N/A - pre-application only |
| Eligibility: | All Faculty - Must include at least 1 intramural scientist as Program Director/Principal Investigator or collaborator, and at least some of the research must be conducted at the NIH Clinical Center. |
| Contact: | Linda Nolan (x6071) |
| FOA Link: | PAR-15-286 |
